[HTML][HTML] Characterization of neutralizing antibodies to West Nile virus

MD Sánchez, TC Pierson, D McAllister, SL Hanna… - Virology, 2005 - Elsevier
MD Sánchez, TC Pierson, D McAllister, SL Hanna, BA Puffer, LE Valentine, MM Murtadha
Virology, 2005Elsevier
We produced nine monoclonal antibodies (MAbs) directed against the West Nile virus E
glycoprotein using three different immunization strategies: inactivated virus, naked DNA, and
recombinant protein. Most of the MAbs bound to conformation dependent epitopes in
domain III of the E protein. Four of the MAbs neutralized WNV infection and bound to the
same region of domain III with high affinity. The neutralizing MAbs were obtained from mice
immunized with inactivated virus alone or in combination with a DNA plasmid. In contrast …
We produced nine monoclonal antibodies (MAbs) directed against the West Nile virus E glycoprotein using three different immunization strategies: inactivated virus, naked DNA, and recombinant protein. Most of the MAbs bound to conformation dependent epitopes in domain III of the E protein. Four of the MAbs neutralized WNV infection and bound to the same region of domain III with high affinity. The neutralizing MAbs were obtained from mice immunized with inactivated virus alone or in combination with a DNA plasmid. In contrast, MAbs obtained by immunization with a soluble version of the E glycoprotein did not exhibit neutralizing activity. These non-neutralizing antibodies were cross-reactive with several other flaviviruses, including Saint Louis encephalitis, Japanese encephalitis, Yellow Fever and Powassan viruses. Interestingly, some non-neutralizing MAbs bound with high affinity to domains I or III, indicating that both affinity and the precise epitope recognized by an antibody are important determinants of WNV neutralization.
Elsevier